Lung cancer a cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Lung Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Breast Epithelial Cells Lymph Nodes Prostate Cell Line HCT116 Cells MCF-7 Cells Bronchi Mediastinum

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases53

Lung Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Small Cell Lung Diseases Adenocarcinoma Small Cell Lung Carcinoma Carcinoma, Squamous Cell Prostatic Neoplasms Neoplasm Metastasis Ovarian Neoplasms Breast Neoplasms Neoplasms Neoplasm Invasiveness Stomach Neoplasms Colonic Neoplasms Genetic Predisposition to Disease Pancreatic Neoplasms Disease Progression Carcinoma, Large Cell Carcinoma Lung Injury Uterine Cervical Neoplasms Urinary Bladder Neoplasms Neoplasm Recurrence, Local Colorectal Neoplasms Cell Transformation, Neoplastic Occupational Diseases Rectal Neoplasms Neoplasms, Radiation-Induced Acute Lung Injury Endometrial Neoplasms Esophageal Neoplasms Neovascularization, Pathologic Neoplasms, Second Primary Bone Neoplasms Head and Neck Neoplasms Precancerous Conditions Liver Neoplasms Adenocarcinoma, Bronchiolo-Alveolar Carcinoma, Bronchogenic Mouth Neoplasms Neoplasms, Multiple Primary Neoplasms, Hormone-Dependent Gastrointestinal Neoplasms Skin Neoplasms Neoplasms, Glandular and Epithelial Genital Neoplasms, Female Lung Diseases, Interstitial Thyroid Neoplasms Mesothelioma Neoplasms, Experimental Pharyngeal Neoplasms Mammary Neoplasms, Experimental

Chemicals and Drugs51

Antineoplastic Agents Tumor Markers, Biological Neoplasm Proteins Cisplatin Cancer Vaccines RNA, Messenger Receptor, Epidermal Growth Factor DNA, Neoplasm Quinazolines Paclitaxel Radon RNA, Small Interfering Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Receptor, erbB-2 Receptors, Estrogen Antigens, Neoplasm Deoxycytidine Protein Kinase Inhibitors Anticarcinogenic Agents Antibodies, Monoclonal Taxoids Prostate-Specific Antigen Carcinogens MicroRNAs Tumor Suppressor Proteins Carboplatin Fluorouracil Tamoxifen Asbestos Receptors, Progesterone Antimetabolites, Antineoplastic Antineoplastic Agents, Hormonal DNA-Binding Proteins RNA, Neoplasm Etoposide Proto-Oncogene Proteins Transcription Factors Air Pollutants, Radioactive Vinblastine Antibodies, Monoclonal, Humanized Proto-Oncogene Proteins c-akt Nuclear Proteins Carcinogens, Environmental Carcinoembryonic Antigen Camptothecin Radiopharmaceuticals ras Proteins DNA Primers Vascular Endothelial Growth Factor A Enzyme Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Early Detection of Cancer Neoplasm Staging Prognosis Survival Analysis Survival Rate Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Reverse Transcriptase Polymerase Chain Reaction Risk Follow-Up Studies Prospective Studies Risk Factors Xenograft Model Antitumor Assays Gene Expression Profiling Pneumonectomy Disease-Free Survival Risk Assessment Registries Combined Modality Therapy Blotting, Western Odds Ratio Neoplasm Transplantation Sensitivity and Specificity Lung Transplantation Treatment Outcome Kaplan-Meier Estimate Transplantation, Heterologous Tumor Burden Chemotherapy, Adjuvant Multivariate Analysis Tomography, X-Ray Computed Immunohistochemistry Oligonucleotide Array Sequence Analysis Drug Screening Assays, Antitumor Incidence Clinical Trials as Topic Molecular Targeted Therapy Predictive Value of Tests Polymerase Chain Reaction Drug Administration Schedule SEER Program Reproducibility of Results Questionnaires Logistic Models Transfection Radiotherapy Cohort Studies Confidence Intervals Immunoenzyme Techniques Case-Control Studies Models, Biological Gene Knockdown Techniques Flow Cytometry Tissue Array Analysis Palliative Care Mammography Bronchoscopy DNA Mutational Analysis Radiotherapy Dosage Positron-Emission Tomography Neoplasm Grading Lung Volume Measurements Radiotherapy, Adjuvant Biopsy Real-Time Polymerase Chain Reaction Immunotherapy In Situ Hybridization, Fluorescence Neoplasms, Experimental Drug Delivery Systems Mammary Neoplasms, Experimental Genetic Therapy

Psychiatry and Psychology1

Phenomena and Processes45

Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Mutation Odds Ratio DNA Methylation Cell Proliferation Sensitivity and Specificity Apoptosis Genotype Cell Survival Polymorphism, Genetic Dose-Response Relationship, Drug Down-Regulation Cell Movement Cell Division Promoter Regions, Genetic Genes, Tumor Suppressor Genes, p53 Cell Cycle Signal Transduction Cell Growth Processes Up-Regulation RNA Interference Transfection Gene Silencing Base Sequence Gene Expression Genes, ras Genes, BRCA1 Genes, Neoplasm Time Factors Phenotype Phosphorylation Alleles Drug Synergism Diet Germ-Line Mutation Epithelial-Mesenchymal Transition Loss of Heterozygosity Gene Amplification Postmenopause DNA Damage Epigenesis, Genetic

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Incidence SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group Asian Continental Ancestry Group

Health Care34

Survival Analysis Survival Rate Retrospective Studies Risk Follow-Up Studies Prospective Studies Risk Factors Disease-Free Survival Risk Assessment Registries Odds Ratio National Cancer Institute (U.S.)Sensitivity and Specificity Age Factors Treatment Outcome Kaplan-Meier Estimate Multivariate Analysis Occupational Exposure Incidence Clinical Trials as Topic Predictive Value of Tests SEER Program Reproducibility of Results Questionnaires Logistic Models Cohort Studies Confidence Intervals American Cancer Society Case-Control Studies Palliative Care Sex Factors Confounding Factors (Epidemiology)Environmental Exposure Age Distribution

Geographicals5

United States Japan China Sweden Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Lung Neoplasms Carcinoma, Non-Small-Cell Lung Lung Early Detection of Cancer Carcinoma, Small Cell Lung Diseases Smoking Adenocarcinoma Small Cell Lung Carcinoma Gene Expression Regulation, Neoplastic Cell Line, Tumor Carcinoma, Squamous Cell Prostatic Neoplasms Neoplasm Metastasis Neoplasm Staging Ovarian Neoplasms Breast Neoplasms Antineoplastic Agents Prognosis Neoplasms Mice, Nude Neoplasm Invasiveness Survival Analysis Stomach Neoplasms Colonic Neoplasms Survival Rate Antineoplastic Combined Chemotherapy Protocols Tumor Markers, Biological Neoplasm Proteins Genetic Predisposition to Disease Retrospective Studies Drug Resistance, Neoplasm Pancreatic Neoplasms Reverse Transcriptase Polymerase Chain Reaction Cisplatin Risk Cancer Vaccines Mutation Follow-Up Studies Disease Progression Carcinoma, Large Cell RNA, Messenger Prospective Studies Risk Factors Xenograft Model Antitumor Assays Gene Expression Profiling Carcinoma Lung Injury Receptor, Epidermal Growth Factor Pneumonectomy DNA, Neoplasm Disease-Free Survival Uterine Cervical Neoplasms Risk Assessment Registries Combined Modality Therapy Blotting, Western Odds Ratio United States Neoplasm Transplantation Quinazolines National Cancer Institute (U.S.)Paclitaxel Radon Urinary Bladder Neoplasms DNA Methylation Cell Proliferation Neoplasm Recurrence, Local RNA, Small Interfering Tumor Cells, Cultured Colorectal Neoplasms Antineoplastic Agents, Phytogenic Sensitivity and Specificity Age Factors Lung Transplantation Treatment Outcome Apoptosis Kaplan-Meier Estimate Tumor Suppressor Protein p53 Cell Transformation, Neoplastic Genotype Cell Survival Transplantation, Heterologous Receptor, erbB-2 Tumor Burden Receptors, Estrogen Survivors Antigens, Neoplasm Polymorphism, Genetic Chemotherapy, Adjuvant Multivariate Analysis Dose-Response Relationship, Drug Down-Regulation Occupational Exposure Cell Movement Deoxycytidine Tomography, X-Ray Computed Immunohistochemistry Oligonucleotide Array Sequence Analysis Drug Screening Assays, Antitumor

No FAQ available that match "lung cancer a cancer"